JP Stock MarketDetailed Quotes

2763 FTGroup

Watchlist

1208
-12-0.98%

20min DelayTrading Dec 16 14:34 JST

36.65BMarket Cap6.94P/E (Static)

FTGroup Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Sep 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

-2.56%9.34B

-10.36%36.48B

-7.39%9.44B

-10.92%8.82B

-9.68%9.58B

-13.56%8.65B

-10.04%40.7B

-18.86%10.19B

-15.06%9.9B

-2.35%10.61B

Cost of revenue

-4.60%5.67B

-14.07%22.2B

-16.19%5.59B

-14.21%5.62B

-3.21%5.94B

-22.02%5.05B

-9.91%25.83B

-24.12%6.66B

-15.27%6.55B

-4.81%6.14B

Gross profit

0.74%3.67B

-3.93%14.28B

9.25%3.85B

-4.45%3.2B

-18.57%3.64B

1.96%3.59B

-10.27%14.86B

-6.62%3.52B

-14.69%3.35B

1.25%4.47B

Operating expense

-96.25%61M

-27.04%6.59B

-29.14%1.74B

-23.96%1.59B

-25.87%1.63B

-28.81%1.62B

-11.35%9.03B

123.36%2.46B

-30.77%2.1B

-28.19%2.2B

Selling and administrative expenses

-5.56%1.55B

-26.70%6.64B

-23.79%1.67B

-25.64%1.6B

-28.30%1.64B

-28.86%1.73B

-31.61%9.06B

-46.89%2.19B

-28.68%2.15B

-24.98%2.28B

-General and administrative expense

-5.56%1.55B

-26.70%6.64B

-23.79%1.67B

-25.64%1.6B

-28.30%1.64B

-28.86%1.73B

-31.61%9.06B

-46.89%2.19B

-28.68%2.15B

-24.98%2.28B

Other operating expenses

2,600.00%81M

-15.65%97M

59.62%83M

-97.30%1M

-70.00%3M

-35.71%9M

-65.26%115M

-78.42%52M

32.14%37M

-77.78%10M

Total other operating income

12,950.00%1.57B

2.70%152M

106.64%14M

-90.53%9M

-87.63%12M

-30.12%116M

-95.64%148M

-106.45%-211M

352.38%95M

223.33%97M

Operating profit

79.22%3.61B

31.81%7.69B

97.66%2.11B

28.24%1.6B

-11.52%2.01B

58.14%1.97B

-8.55%5.84B

-60.10%1.07B

39.66%1.25B

67.58%2.27B

Net non-operating interest income (expenses)

-25.00%-5M

-21.43%11M

90.00%-5M

-76.92%9M

-128.57%-4M

0.00%11M

-84.78%14M

-190.91%-50M

4,000.00%39M

133.33%14M

Non-operating interest income

-33.33%2M

-32.79%41M

104.88%2M

-65.96%16M

-86.96%3M

-38.71%19M

-66.30%61M

-154.67%-41M

123.81%47M

-17.86%23M

Non-operating interest expense

0.00%7M

-36.17%30M

-22.22%7M

-12.50%7M

-22.22%7M

-60.00%8M

-47.19%47M

-55.00%9M

-63.64%8M

-59.09%9M

Net investment income

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

Other non-operating income (expenses)

Income before tax

79.37%3.6B

31.69%7.71B

106.68%2.1B

25.00%1.61B

-12.28%2.01B

57.88%1.98B

-9.64%5.85B

-62.71%1.02B

44.23%1.29B

67.99%2.29B

Income tax

56.68%1.01B

8.76%2.42B

36.13%648M

3.91%505M

-9.17%644M

12.45%623M

34.10%2.23B

31.86%476M

35.38%486M

58.97%709M

Net income

90.10%2.59B

45.77%5.28B

168.63%1.46B

37.78%1.11B

-13.68%1.36B

93.87%1.36B

-24.70%3.63B

-77.11%542M

50.19%802M

72.57%1.58B

Net income continuous operations

90.10%2.59B

45.77%5.28B

168.63%1.46B

37.78%1.11B

-13.68%1.36B

93.73%1.36B

-24.71%3.63B

-77.12%542M

50.19%802M

72.38%1.58B

Noncontrolling interests

Net income attributable to the company

90.10%2.59B

45.77%5.28B

168.63%1.46B

37.78%1.11B

-13.68%1.36B

93.87%1.36B

-24.70%3.63B

-77.11%542M

50.19%802M

72.57%1.58B

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

90.10%2.59B

45.77%5.28B

168.63%1.46B

37.78%1.11B

-13.68%1.36B

93.87%1.36B

-24.70%3.63B

-77.11%542M

50.19%802M

72.57%1.58B

Gross dividend payment

Basic earnings per share

92.46%85.97

47.53%174.04

170.12%48.19

39.20%36.4

-12.92%44.67

97.18%44.76

-24.18%117.97

-76.69%17.84

51.42%26.15

73.37%51.3

Diluted earnings per share

92.46%85.97

48.54%174.04

171.95%48.19

40.11%36.4

-12.34%44.67

98.58%44.76

-24.19%117.17

-76.69%17.72

51.49%25.98

73.39%50.96

Dividend per share

0.00%20

0.00%55

0.00%35

0.00%20

-12.70%55

0.00%35

-28.57%20

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q2)Sep 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	-2.56%9.34B	-10.36%36.48B	-7.39%9.44B	-10.92%8.82B	-9.68%9.58B	-13.56%8.65B	-10.04%40.7B	-18.86%10.19B	-15.06%9.9B	-2.35%10.61B
Cost of revenue	-4.60%5.67B	-14.07%22.2B	-16.19%5.59B	-14.21%5.62B	-3.21%5.94B	-22.02%5.05B	-9.91%25.83B	-24.12%6.66B	-15.27%6.55B	-4.81%6.14B
Gross profit	0.74%3.67B	-3.93%14.28B	9.25%3.85B	-4.45%3.2B	-18.57%3.64B	1.96%3.59B	-10.27%14.86B	-6.62%3.52B	-14.69%3.35B	1.25%4.47B
Operating expense	-96.25%61M	-27.04%6.59B	-29.14%1.74B	-23.96%1.59B	-25.87%1.63B	-28.81%1.62B	-11.35%9.03B	123.36%2.46B	-30.77%2.1B	-28.19%2.2B
Selling and administrative expenses	-5.56%1.55B	-26.70%6.64B	-23.79%1.67B	-25.64%1.6B	-28.30%1.64B	-28.86%1.73B	-31.61%9.06B	-46.89%2.19B	-28.68%2.15B	-24.98%2.28B
-General and administrative expense	-5.56%1.55B	-26.70%6.64B	-23.79%1.67B	-25.64%1.6B	-28.30%1.64B	-28.86%1.73B	-31.61%9.06B	-46.89%2.19B	-28.68%2.15B	-24.98%2.28B
Other operating expenses	2,600.00%81M	-15.65%97M	59.62%83M	-97.30%1M	-70.00%3M	-35.71%9M	-65.26%115M	-78.42%52M	32.14%37M	-77.78%10M
Total other operating income	12,950.00%1.57B	2.70%152M	106.64%14M	-90.53%9M	-87.63%12M	-30.12%116M	-95.64%148M	-106.45%-211M	352.38%95M	223.33%97M
Operating profit	79.22%3.61B	31.81%7.69B	97.66%2.11B	28.24%1.6B	-11.52%2.01B	58.14%1.97B	-8.55%5.84B	-60.10%1.07B	39.66%1.25B	67.58%2.27B
Net non-operating interest income (expenses)	-25.00%-5M	-21.43%11M	90.00%-5M	-76.92%9M	-128.57%-4M	0.00%11M	-84.78%14M	-190.91%-50M	4,000.00%39M	133.33%14M
Non-operating interest income	-33.33%2M	-32.79%41M	104.88%2M	-65.96%16M	-86.96%3M	-38.71%19M	-66.30%61M	-154.67%-41M	123.81%47M	-17.86%23M
Non-operating interest expense	0.00%7M	-36.17%30M	-22.22%7M	-12.50%7M	-22.22%7M	-60.00%8M	-47.19%47M	-55.00%9M	-63.64%8M	-59.09%9M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
Income before tax	79.37%3.6B	31.69%7.71B	106.68%2.1B	25.00%1.61B	-12.28%2.01B	57.88%1.98B	-9.64%5.85B	-62.71%1.02B	44.23%1.29B	67.99%2.29B
Income tax	56.68%1.01B	8.76%2.42B	36.13%648M	3.91%505M	-9.17%644M	12.45%623M	34.10%2.23B	31.86%476M	35.38%486M	58.97%709M
Net income	90.10%2.59B	45.77%5.28B	168.63%1.46B	37.78%1.11B	-13.68%1.36B	93.87%1.36B	-24.70%3.63B	-77.11%542M	50.19%802M	72.57%1.58B
Net income continuous operations	90.10%2.59B	45.77%5.28B	168.63%1.46B	37.78%1.11B	-13.68%1.36B	93.73%1.36B	-24.71%3.63B	-77.12%542M	50.19%802M	72.38%1.58B
Noncontrolling interests
Net income attributable to the company	90.10%2.59B	45.77%5.28B	168.63%1.46B	37.78%1.11B	-13.68%1.36B	93.87%1.36B	-24.70%3.63B	-77.11%542M	50.19%802M	72.57%1.58B
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	90.10%2.59B	45.77%5.28B	168.63%1.46B	37.78%1.11B	-13.68%1.36B	93.87%1.36B	-24.70%3.63B	-77.11%542M	50.19%802M	72.57%1.58B
Gross dividend payment
Basic earnings per share	92.46%85.97	47.53%174.04	170.12%48.19	39.20%36.4	-12.92%44.67	97.18%44.76	-24.18%117.97	-76.69%17.84	51.42%26.15	73.37%51.3
Diluted earnings per share	92.46%85.97	48.54%174.04	171.95%48.19	40.11%36.4	-12.34%44.67	98.58%44.76	-24.19%117.17	-76.69%17.72	51.49%25.98	73.39%50.96
Dividend per share	0.00%20	0.00%55	0.00%35	0	0.00%20	0	-12.70%55	0.00%35	0	-28.57%20
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

See the daily top gainer.